CANCER DRUG DEVELOPMENT

Save this PDF as:
Size: px
Start display at page:

Download "CANCER DRUG DEVELOPMENT"

Transcription

1 FACILITATING SUCCESSFUL CANCER DRUG DEVELOPMENT TURNING TRIALS INTO THERAPY TRIAL ACCELERATION SERVICES: Physician-Focused Patient Recruitment TRANSLATING INNOVATION INTO PATIENT CARE CLINICAL APPLICATION PROGRAMS: Tumor and Translational Summits ONE SOURCE FOR CANCER KNOWLEDGE STRATEGIC DECISION MAKING: Innovative Reference Tools and Clinical Insights CAPABILITIES

2 xxxxx Oncology Meeting Innovations advancing knowledge 2016 Program Overview 2

3 OMI: Non-CME Clinical Application Programs MULTI-SUPPORTED Global and National Summits Regional Summits Expert Forums SOLE-SUPPORTED Advisory Boards Ex-US Global Summits Ex-US Expert Forums OUR PROGRAMS ARE: Fair and Balanced Non-Promotional Sunshine Act Compliant 3

4 Global and National Summits ATTENDANCE KEY OBJECTIVES DELIVERABLES 2-3 days 30+ academic faculty 50+ community oncologists 10+ fellows Classroom-style Discuss and debate emerging preclinical and clinical data Challenges in patient care with next generation agents Integrating companion diagnostics into patient care How will treatment guidelines change in the future? How will current practice evolve in the next 2-5 years? OTHER OPPORTUNITIES LIVE Registrations On-Demand Multimedia Experience Summit Synopsis Report Advisory Boards: Slots are available at any Summit and are solely reserved for our industry members Emerging Technologies Showcase: Biotech and pharma companies present on novel therapies and early pipeline compounds DAVA Research Consortium (DRC) Meeting: Private time with our network of physicians engaged in clinical research 4

5 Expert Forums ATTENDANCE KEY OBJECTIVES DELIVERABLES 1-2 days 20+ academic faculty Think Tank, U-style room Assemble a distinguished group of preclinical and translational experts High-level scientific discussion on current research into genomics and new molecular targets Focus on molecular diagnostics, genomic analysis, and evolution of care Practical clinical oncology approaches with new and existing agents LIVE Registrations On-Demand Multimedia Experience Summit Synopsis Report ADVISORY BOARD OPPORTUNITIES Advisory Board slots are available at any Expert Forum and are solely reserved for our industry members 5

6 OMI National Summit & Expert Forum Calendar NATIONAL SUMMITS THORACIC MALIGNANCIES AND HEAD & NECK CANCER September Los Angeles, CA Suresh Ramalingam, MD Emory University Ravi Salgia, MD, PhD City of Hope National Medical Center Everett Vokes, MD, FASCO University of Chicago GENITOURINARY MALIGNANCIES October New York City, NY Charles J. Ryan, MD University of California, San Francisco Oliver Sartor, MD Tulane University Walter Stadler, MD University of Chicago LEUKEMIA, LYMPHOMA & MULTIPLE MYELOMA March/April, 2017 Whistler, BC Canada John Byrd, MD Ohio State University Sundar Jagannath, MD Mount Sinai Hospital Sagar Lonial, MD Emory University Wyndham Wilson, MD, PhD National Cancer Institute APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR EXPERT FORUMS MULTIPLE MYELOMA September Atlanta, GA Sagar Lonial, MD Emory University School of Medicine Keith Stewart, MB, CHB Mayo Clinic in Arizona Paul Richardson, MD Dana-Farber Cancer Institute Sundar Jagannath, MD Mount Sinai School of Medicine HARNESSING THE IMMUNE SYSTEM IN CANCER November Dallas, TX Mario Sznol, MD Yale University Roy Herbst, MD, PhD Yale University David Porter, MD University of Pennsylvania ACUTE LEUKEMIA & MYELOPROLIFERATIVE NEOPLASMS January 2017 Dallas, TX Jorge Cortes, MD University of Texas, MD Anderson Cancer Center Richard Silver, MD Cornell University Jerry Spivak, MD John Hopkins University 6

7 Regional Summits ATTENDANCE KEY OBJECTIVES DELIVERABLES 1 day, 6-hour program 5-7 academic faculty 30+ community oncologists Classroom-style Audience Response System What is the best way to utilize the agents available today? Discuss and debate current treatment approaches Identification and management of patient toxicities New therapies on the horizon Challenging patient case studies ADVISORY BOARD OPPORTUNITIES LIVE Registrations On-Demand Multimedia Experience Summit Synopsis Report Advisory Board slots are available at any Regional Summit and are solely reserved for our industry members 7

8 Advisory Boards ATTENDANCE KEY OBJECTIVES DELIVERABLES By-invitation only 4-6 hours 8-12 academic and/or community experts Medical and clinical focus Evaluation of new clinical data Clinical development planning Commercial and marketing focus Utilization validation Identification & recruitment Discussion guide development Content development Meeting planning & execution MD moderation On-site support Executive summary & action plan OPPORTUNITIES Advisory Board opportunities available at all Summits, Expert Forums, major conferences, and standalone Advisory Boards in conjunction with OMI Programs are solely reserved for our industry members 8

9 Industry Membership Packages MEMBERSHIP LEVEL MEMBERSHIP LEVEL LIVE REGISTRATIONS LIVE REGISTRATIONS PHARMA MEMBERSHIP BENEFITS ON-DEMAND AND REPORT LICENSES BIOTECH MEMBERSHIP BENEFITS ON-DEMAND AND REPORT LICENSES RECOGNITION RECOGNITION Charter 5 7 Distinguished 3 5 Core 2 3 DISPLAY Charter Unlimited Unlimited Distinguished 5 10 Core 3 5 DISPLAY LIVE Registrations On-Demand Multimedia Experience Summit Synopsis Report Recognition and Display Booth DELIVERABLES Representatives from Clinical Development, Commercial, Medical Affairs, New Products and Life Cycle Planning LIVE streaming of the program in real-time On-Demand Agenda: Clickable document giving access to the audio/video recorded lectures and slides, distributed a week after the meeting Executive Summary pdf of plenary lectures, including key learning objectives, images/graphs, and Q&A/discussion points Verbal and written recognition in signage/booklets Prominence depends on membership level Display opportunities at Summits only 9

10 On-Demand Multimedia Experience Remote Meeting Experience (LIVE streaming) LIVE meeting experience from anywhere in the world with audio/video integration Interactive aspects of the platform create a seamless experience for external users High-resolution Features presenters and slides Ability to toggle between slide share and full screen video grid for the best discussion experience High-Resolution Content Distribution Virtual attendees can connect using any mobile or traditional computing device Supports Android, Apple, and Windows On-Demand Access Clickable agenda for access to the archived meeting audio/video and slide presentations Offline viewing of videos through DVD and USB available upon request 10

11 Summit Synopsis Report Executive summary of meeting highlights & analysis of key takeaways Access to On-Demand Agenda in Table of Contents KOL feedback and community input Case-based presentation outcomes Impact of new and emerging agents Clinical development strategies Integration of new therapies into the standard of care In an easy-to-use, clickable pdf format 11

12 ONCOLOGY MEETING INNOVATIONS LEADERSHIP TEAM MARK LEVONYAK President Mobile: JOHN ECKARDT, MD Chief Medical Officer Mobile: GREGORY PYNES, MPA Director, Meetings Mobile: TIM CASON Manager, Business Development Mobile: Follow DAVA Oncology on social media! JESSICA OLIVARES, MBA Senior Project Manager Mobile: TINA NGHIEM Project Manager Mobile: Lincoln Center Two, 5420 Lyndon B Johnson Fwy, Suite 410, Dallas, TX I